Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5541)
All Articles published online
|
Publishing Process of This Article
|
Feb 7, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghiringhelli F, Isambert N, Ladoire S. Degarelix as a new antiangiogenic agent for metastatic colon cancer? World J Gastroenterol 2013; 19(5): 769-772 [PMID: 23431078 DOI: 10.3748/wjg.v19.i5.769] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i5/769.htm |
| Number | Citing Articles |
| 1 |
Blaise Robin, François Planeix, Xavier Sastre-Garau, Christophe Pichon, Tine Kold Olesen, Jean Gogusev, Nicolae Ghinea. Follicle-Stimulating Hormone Receptor Expression in Endometriotic Lesions and the Associated Vasculature: An Immunohistochemical Study. Reproductive Sciences 2016; 23(7): 885 doi: 10.1177/1933719115623647
|
| 2 |
Monica Sakai, Daniel B. Martinez-Arguelles, Nathan H. Patterson, Pierre Chaurand, Vassilios Papadopoulos, Natasha Kyprianou. In Search of the Molecular Mechanisms Mediating the Inhibitory Effect of the GnRH Antagonist Degarelix on Human Prostate Cell Growth. PLOS ONE 2015; 10(3): e0120670 doi: 10.1371/journal.pone.0120670
|
| 3 |
ARTURO AGUILAR-ROJAS, MARCO ALLAN PÉREZ-SOLIS, GUADALUPE MAYA-NÚÑEZ. The gonadotropin-releasing hormone system: Perspectives from reproduction to cancer (Review). International Journal of Oncology 2016; 48(3): 861 doi: 10.3892/ijo.2016.3346
|
| 4 |
G. Ploussard, F. Bruyère, S. Culine, A. de La Taille, C. Hennequin, S. Oudard, C. Pfister, V. Ravery, L. Salomon. Modalités de castration dans la prise en charge du cancer de la prostate : sont-elles toutes équivalentes ?. Progrès en Urologie 2016; 26(5): 319 doi: 10.1016/j.purol.2016.02.010
|
| 5 |
Wojciech Marlicz, Agata Poniewierska-Baran, Sylwia Rzeszotek, Rafał Bartoszewski, Karolina Skonieczna-Żydecka, Teresa Starzyńska, Mariusz Z. Ratajczak, Daniel J. Bernard. A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer. PLOS ONE 2018; 13(3): e0189337 doi: 10.1371/journal.pone.0189337
|
| 6 |
Suocheng Wei, Luju Lai, Juan Yang, Gong Zhuandi. Expression Levels of Follicle-Stimulating Hormone Receptor and Implication in Diagnostic and Therapeutic Strategy of Ovarian Cancer. Oncology Research and Treatment 2018; 41(10): 651 doi: 10.1159/000490810
|
| 7 |
François Planeix, Mohammad-Ahsan Siraj, François-Clément Bidard, Blaise Robin, Christophe Pichon, Xavier Sastre-Garau, Martine Antoine, Nicolae Ghinea. Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0128-7
|
| 8 |
Konstantinos Papadimitriou, Panteleimon Kountourakis, Anastasia E. Kottorou, Anna G. Antonacopoulou, Christian Rolfo, Marc Peeters, Haralabos P. Kalofonos. Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?. Molecular Diagnosis & Therapy 2016; 20(6): 523 doi: 10.1007/s40291-016-0218-z
|